SMG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Scotts Miracle-Gro Co (SMG) is not a strong buy for a beginner investor with a long-term strategy at this time. While there are some positive signals like bullish moving averages and improved financial metrics, the lack of strong trading signals, neutral sentiment from hedge funds and insiders, and limited upside potential based on analyst ratings and price targets suggest holding off on immediate investment.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), and the MACD histogram is positive, indicating a bullish trend. However, RSI is neutral at 63.48, and the stock is trading near its pivot level of 69.178, with resistance at 71.68 and support at 66.676. The technical setup is moderately positive but not strongly compelling.
Improved financial metrics in Q1 2026, including a significant YoY increase in Net Income (+79.86%) and EPS (+78.51%), as well as a slight increase in Gross Margin (+3.59%). Wells Fargo raised the price target to $75 and maintains an Overweight rating.
UBS maintains a Neutral rating with a modest price target increase to $
No recent news or significant trading activity from hedge funds, insiders, or Congress. Options data shows relatively low implied volatility and volume, indicating limited market enthusiasm.
In Q1 2026, revenue dropped by -3.33% YoY to $354.4M. However, Net Income improved significantly to -$125M (+79.86% YoY), and EPS increased to -2.16 (+78.51% YoY). Gross Margin also rose to 25.4% (+3.59% YoY), showing some operational improvement despite revenue challenges.
Wells Fargo raised the price target to $75 from $70 and maintains an Overweight rating, citing a strong start for the Staples sector. UBS raised the price target to $67 from $66 but keeps a Neutral rating, reflecting limited confidence in significant upside.
